Skip to main content

Glossary

ANTIMICROBIAL

A substance with properties capable of destroying or inhibiting the growth of microorganisms (e.g. bacteria).

 

DERMATOLOGY

The science of the skin and its diseases.

 

DRUG DELIVERY

The method or process of administering active compounds to achieve a therapeutic effect in humans or animals. Drug delivery technologies refer to patent-protected formulation technologies that modify drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy and safety, as well as patient convenience and/or reduced side effects. Drug delivery technologies pertain to patent-protected formulation technologies that result in changed properties in respect of, for example, the release or absorption of a drug in the body in order to achieve a more effective and simpler treatment and/or reduced side effects.

 

ECZEMA

Eczema is a non-contagious skin disease caused by an inflammation in the epidermis. The term eczema is used for several types of skin rashes that are characterized by redness, itching, dryness and peeling.

 

FORMULATION

To develop the most appropriate formulation of a pharmaceutical, for example, cream, tablet or liquid form.

 

KERATOLYTIC

To remove/shed dead cells from the epidermis/nail.

 

CLINICAL STUDIES

A study of the effects of a pharmaceutical on humans.

 

LINE EXTENSIONS

New article, usually with unique characteristics, within a previously established product family.

 

MICROSCOPY

Studies at a microscopic level of objects that are not visible to the eye.

 

MYCOLOGY

The study of fungi.

 

NAIL FUNGUS

Fungus infection of the nail that often results in the thickening and crumbling of the nail and the separation of the nail from the nail bed. Nail fungus is normally caused by dermatophytes.

 

PATENT FAMILY

A patent family consists of all patents and patent applications submitted in different countries for the same invention.

 

PREVALENCE

The number of individuals in a certain group having a certain disease at a certain time.

 

TERBINAFINE

An antifungal agent, developed by Novartis, now without patent protection. It belongs to a class of pharmaceuticals called allylamines, which block the activity of an enzyme, squalene epoxidase, which has a central role in the synthesis of the fungal cell membrane.